Forskrifter
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
FDA
MHRA
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO-liste
Kliniske forsøg
US Clinical Trials Registry
EU Kliniske forsøgsregister
Farmaceutiske virksomheder
Kliniske forskningslaboratorier
Servicevirksomheder
Clinical Research Events
Publikationer
Forskere
Job
Publikationer
Nyheder
Denne side blev automatisk oversat, og nøjagtigheden af oversættelsen er ikke garanteret. Der henvises til
engelsk version
for en kildetekst.
ICH GCP
US Clinical Trials Registry
Search trials
Tilstand eller sygdom:
Intervention/Behandling:
Sponsor:
Beliggenhed:
Kun rekruttering og endnu ikke rekruttering af studier
Kliniske forsøg med Urolitiáza
I alt 0 resultater
Intet fundet
Sponsorer og samarbejdspartnere
Mª Victoria Maestre Sanchez
GFI
Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Kupfer, David J., M.D.
Aptis Medical
Neurophth Therapeutics Inc
Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
Everett Meyer
Agency for Science, Technology and Research
Hospital Durand, Argentina
Eurofins Genoma
ASST Cremona, Cremona
Hospital ASEPEYO Sant Cugat
Alma Lasers Inc.
Nacuity Pharmaceuticals, Inc.
Korean Society of Spine Surgery
Apollo Neuroscience, Inc.
iCAD
Principal Investigator Mohanad Omar Ahmed, Msc Pharmacy Practice Department- Horus University
RMIT University, Melbourne, Australia
Se den fulde liste
Medicinske tilstande
Scleredema
STAGE IIIA/B NSCLC / UOPPERabel Lungekræft
Dienogest
Behandlingsbeslutninger
Tilbagevendende klarcellet sarkom af blødt væv
Major Liver Surgery
Immun-medieret inflammatorisk sygdom
Symptomer på kronisk obstipation
Reumatoid arthritis (RA)
Forstyrrelse af væskebalancen
Metakront adenom
24 timers esophageal PH og multikanal intraluminal impedanstest
Korneal krydsbinding
Lutealfasestøtte
Milt trauma
T-LGL leukæmi
Aortaens styrkeegenskaber in vitro
Feber
Mavekræft Stadium IIIB-IIIC
RISS Stadium III Plasmacellemyelom
Se den fulde liste
Narkotikainterventioner
GLPG1837 flere stigende doser
Intravenøs formulering af PD-0332991
Desvenlafaxin
Capecitabin/cisplatin
Fospropofol dinatrium, propofol
Capecitabin og IMRT (hvis randomiseret til denne arm)
THC
Standardbehandling (SOC) for COVID-19
MLN2480
Camptosar
Intravenøs deferipron
Olopatadin
Oxycodon/acetaminophen 5/325 mg
TPN-101
OnabotulinumtoxinA
Midazolam
Antikolinergisk
RDX227675
Letrozol
PD-1/PD-L1-hæmmer
Se den fulde liste
CROs by country
Contract Research Organizations in Congo
Contract Research Organizations in Cyprus
Contract Research Organizations in Ecuador
Contract Research Organizations in France
Contract Research Organizations in Guatemala
Contract Research Organizations in Hong Kong
Contract Research Organizations in Kuwait
Contract Research Organizations in Macedonia
Contract Research Organizations in New Zealand
Contract Research Organizations in Peru
Contract Research Organizations in Philippines
Contract Research Organizations in Qatar
Contract Research Organizations in Sri Lanka
CRO list by country
CROs in Serbia
Comac Medical
Worldwide Clinical Trials
Syneos Health
EastHORN Clinical Services
ICON
IQVIA
SanaClis
PrimeVigilance
PSI
Fidelis Research
All CROs in Serbia
3
✕
GOOD CLINICAL PRACTICE NETWORK
Abonner for at modtage meddelelser om lovgivningsmæssige opdateringer og industrinyheder!
Abonner
GOOD CLINICAL PRACTICE NETWORK
Abonner for at modtage meddelelser om lovgivningsmæssige opdateringer og industrinyheder!
Abonner
Abonner